Drugs · Brain health technique
Erythropoietin (EPO) Analogs
Evidence grade: Experimental

Biologic drugs that stimulate red blood cell production and may have neurotrophic and vascular effects. Includes epoetin alfa (Epogen®, Procrit®) and darbepoetin alfa (Aranesp®), studied experimentally for neuroprotection in stroke, TBI, and neurodegeneration.
- Practice
- Drugs
- Principle
- Treatment
- Tactic
- Emerging Longevity / Neuroregenerative Agents
- Evidence grade
- Experimental
- Strength of evidence
- Low
How to practice Erythropoietin (EPO) Analogs
Use only under medical supervision or in research settings. Approved clinically for anemia in renal disease or chemotherapy, not for neuroprotection. Typical neuro trials use low-dose IV or subcutaneous regimens (e.g., 40,000 IU weekly). Avoid off-label use due to clotting risk and uncertain long-term safety for brain applications.
The evidence behind Erythropoietin (EPO) Analogs
EPO (erythropoietin) is a hormone that tells your body to make red blood cells. EPO and drugs that mimic it (analogs) boost oxygen delivery and in lab studies help protect cells from dying. Doctors use these drugs to treat anemia from kidney disease or chemotherapy. These drugs can cause blood clots and raise blood pressure, and the risk grows with higher doses.
Impact on brain health
In lab and animal studies, EPO acts on nerve cells and their support cells, supporting their growth and survival through protective pathways in their mitochondria. In animals, it reduced nerve cell death after a loss of blood flow. Small human studies suggest possible gains in thinking and mood after traumatic brain injury and in depression, but whether EPO protects the brain in people is unproven.
Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science
More Drugs techniques
Pair this with other habits from the same practice.

Evidence grade: Context Dependent
Anti-Amyloid Monoclonal Antibodies
FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

Evidence grade: Context Dependent
Antihypertensives
Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

Evidence grade: Context Dependent
GLP-1 Receptor Agonists
A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.
Take control of your brain health
BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.